Understanding GLP-1 medications
An educational overview of GLP-1 medicines: what they are, how they work, who they are prescribed for, common side effects and important warnings. This page does not recommend any product.
On this page
Key takeaways
- GLP-1 medicines mimic a hormone that acts on the parts of the brain that regulate appetite and food intake.
- They are prescription medicines for specific groups of people, not for changing appearance.
- They work best combined with healthy eating and physical activity, which they do not replace.
- Common side effects include nausea, vomiting, diarrhea and constipation. Some rare side effects are serious.
- They carry a warning about thyroid tumors, including a type of thyroid cancer. People with a personal or family history of medullary thyroid cancer or MEN 2 should not take them.
GLP-1 stands for glucagon-like peptide-1, a hormone. GLP-1 medicines mimic it to target areas of the brain that regulate appetite and food intake [1]. This page explains what these medicines are and what to ask about. It is not a recommendation to use any medicine, and it does not compare products.
Which medicines are in this groupLink to section: Which medicines are in this group
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) lists these injected medicines approved by the FDA for long-term weight management that act on GLP-1 [1]:
- Liraglutide, given daily by injection, which the NIDDK says mimics GLP-1
- Semaglutide, given weekly by injection, which the NIDDK says mimics GLP-1
- Tirzepatide, given weekly by injection, which the NIDDK says mimics two hormones, GIP and GLP-1
The NIDDK notes that some of these medicines are also approved, under different names or doses, to treat type 2 diabetes [1]. For details on one of them, see semaglutide.
How they workLink to section: How they work
MedlinePlus explains that semaglutide helps the pancreas release the right amount of insulin when blood sugar is high, slows emptying of the stomach, and may decrease appetite and cause weight loss [2].
Who they are prescribed forLink to section: Who they are prescribed for
The NIDDK says a clinician may prescribe a weight-management medicine for adults with a BMI of 30 or greater, or a BMI of 27 or greater with weight-related health problems such as high blood pressure or type 2 diabetes [1]. They are not for everyone with a high BMI, and the NIDDK says never to take a weight-management medicine only to improve the way you look [1].
What the research showsLink to section: What the research shows
The NIDDK says that, when combined with a lifestyle program, adults taking prescription weight-management medicines lose on average 3% to 12% more of their starting body weight after 1 year than people in a lifestyle program without medicine [1]. Results vary by medicine and by person, and most weight loss happens in the first 6 months [1].
Medicines do not replace healthy eating and physical activity; the NIDDK says they work best combined with a lifestyle program [1]. You will probably regain some weight after stopping [1].
Side effects and warningsLink to section: Side effects and warnings
MedlinePlus lists nausea, vomiting, diarrhea, stomach pain, constipation, heartburn and headache among the side effects of semaglutide injection [2]. Call a doctor immediately or get emergency care for serious symptoms such as ongoing pain that begins in the upper left or middle of the stomach and may spread to the back, signs of an allergic reaction, decreased urination or swelling of the legs, vision changes, or a rapid or pounding heartbeat [2].
Important warnings from our sources include:
- Thyroid tumors: MedlinePlus says semaglutide injection may increase the risk of thyroid tumors, including a type of thyroid cancer; it caused thyroid tumors in rats, and it is not known whether it does in humans [2]. People with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN 2) should not take GLP-1 weight-management medicines [1][2].
- Other conditions: tell your doctor about any history of pancreatitis, diabetic retinopathy, severe stomach problems, gallbladder disease or kidney disease [2].
- Pregnancy: do not take weight-management medicines during pregnancy or if you are planning a pregnancy [1].
- Combining with other diabetes medicines: taking semaglutide with insulin or a sulfonylurea can raise the risk of low blood sugar, including severe low blood sugar — the clinician may adjust other diabetes medicines [4]. See type 2 diabetes for more on low blood sugar.
- Mood: the NIDDK notes that people taking certain weight-loss medicines have reported suicidal thoughts or actions, and the FDA continues to look into whether the medicine is the cause [1].
Questions to ask your clinicianLink to section: Questions to ask your clinician
The NIDDK suggests weighing the likely benefits, possible side effects, your current health and other medicines, your family history and cost [1]. It also advises buying medicine only from a pharmacy or online distributor your health care professional approves, and not combining weight-loss medicines with other weight-loss products unless prescribed [1]. Some, but not all, insurance plans cover these medicines [1].
Unapproved, compounded and counterfeit versionsLink to section: Unapproved, compounded and counterfeit versions
The FDA says unapproved versions of GLP-1 drugs, including compounded semaglutide and tirzepatide, do not go through FDA review for safety, effectiveness and quality before they are sold [3]. It is also aware of counterfeit and illegally marketed versions sold online, which may contain the wrong ingredient or too little, too much or none of the active ingredient [3]. The FDA recommends getting a prescription from your doctor, filling it at a state-licensed pharmacy, and being wary of sellers that do not require a prescription [3].
For the bigger picture, see overweight and obesity and weight management basics. Talk to your pharmacist or clinician about whether any of these medicines is appropriate for you.